Clinical Trials Browser

Cerebral Cavernous Malformations 3, Cerebral Cavernous Malformations 2, Hemangioma, Cavernous, Hemangioma, Capillary, Hemangioma, Cavernous, Central Nervous System

NCT05148663 2023-09-01

CCM Blood Biomarker Validation Study

Terminated

12 enrolled

CNS

Hemorrhagic Stroke, Hemangioma, Cavernous, Central Nervous System

NCT02946866 2022-05-12

CHOCOOATE

Unknown

228 enrolled

CNS

Cerebral Hemorrhage, Hemangioma, Cavernous, Central Nervous System

NCT04076449 2019-09-04

CRESS

Recruiting

200 enrolled

CNS

Epilepsy, Hemangioma, Cavernous, Seizures, Hemangioma, Cavernous, Central Nervous System

NCT03467295 2018-03-19

TOUCH

Unknown

2,000 enrolled

CNS

Hemangioma, Cavernous, Central Nervous System

Clinical Trials

Biomarkers of CASH

Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations

Modifiers of Disease Severity in Cerebral Cavernous Malformations

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

CCM Blood Biomarker Validation Study

CHOCOOATE

CRESS

TOUCH